PTGX position history
The shares of Protagonist Therapeutics (PTGX) that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 15,999 shares, $884K, <0.01% of portfolio, New
- 2025 Q3: 20,325 shares, $1.4M, <0.01% of portfolio, Add +27.0%
- 2025 Q4: 20,349 shares, $1.8M, <0.01% of portfolio, Add +0.1%
- 2026 Q1: 24,337 shares, $2.6M, 0.02% of portfolio, Add +19.6%
- 2026 Q2: 22,651 shares, $2.8M, 0.02% of portfolio, Reduce −6.9%
- 2026 Q3: 20,963 shares, $3M, 0.03% of portfolio, Reduce −7.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|